STAT+: FTC settles lawsuit with Express Scripts over charges it manipulated insulin prices, impeded access
Stat News • 2/4/2026
Summary
The FTC settled a lawsuit with Express Scripts over allegations that the company manipulated insulin prices. The charges included claims that Express Scripts artificially inflated the price of insulin and impeded access to treatment.
Advertisement
Lindy Score Breakdown (V4.2)
58d
Age
1
Sources
from cluster
1385
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1385/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1385/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 57 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more
Stat News • 1 day ago
STAT+: Medicare Advantage plans win extra $18.6 billion as feds cut star ratings measures
Stat News • Today
Opinion: STAT+: Cardiology’s finally prioritizing prevention — but what will it look like?
Stat News • 1 day ago
STAT+: The biotech scorecard for the second quarter: 23 stock-moving events to watch
Stat News • 2 days ago
STAT reporter goes up against radiologists to spot deepfake X-rays
Stat News • 1 day ago
STAT+: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?
Stat News • 1 day ago
STAT+: The HSA industry makes its MAHA pitch
Stat News • 2 days ago
STAT+: NIH director’s invocation of Vannevar Bush’s legacy to promote Trump science policies sparks pushback
Stat News • 2 days ago
STAT+: HHS changes the U.S. health IT office’s name, and its purview
Stat News • 2 days ago
Anti-Lindy Similar stories
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 4 days ago